William George Kaelin, M.D.
Title Sidney Farber Professor of Medicine Institution Dana-Farber Cancer Institute Address Dana Farber Cancer Institute Medicine-Oncology M 457 44 Binney St Boston MA 02115
|
|
Mentoring
Establishment of a Robust Xenograft Mouse Model of IDH-mutant Glioblastoma
Summer, 06/01/14 - 09/01/14
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R35CA210068
(KAELIN, WILLIAM G.)
Sep 1, 2016 - Aug 31, 2023
New Paradigms for Targeting Truncal Driver Mutations
Role: Principal Investigator
-
P50CA165962
(BATCHELOR, TRACY T)
Sep 19, 2013 - Aug 31, 2024
SPORE: Targeted Therapies for Glioma
Role: Co-Principal Investigator
-
R21CA124988
(KAELIN, WILLIAM G)
Dec 15, 2006 - Nov 30, 2008
A Luciferase Fusion Protein Library to Identify &Monitor Ubiquitylation Targets
Role: Principal Investigator
-
R13CA124261
(KAELIN, WILLIAM G)
Jul 25, 2006 - Jun 30, 2007
2006 Cancer Model Mechanisms
Role: Principal Investigator
-
R33CA099069
(KAELIN, WILLIAM G)
Jun 10, 2004 - Apr 30, 2007
Real-Time Imaging of Hypoxia based on VHL Activity
Role: Principal Investigator
-
R21CA099069
(KAELIN, WILLIAM G)
Jun 10, 2004 - Apr 30, 2005
Real-Time Imaging of Hypoxia based on VHL Activity
Role: Principal Investigator
-
R21CA104940
(KAELIN, WILLIAM G)
Mar 12, 2004 - Feb 28, 2006
Using Synthetic Lethality to Select Cancer Drug Targets
Role: Principal Investigator
-
P50CA101942
(KAELIN, WILLIAM G.;MCDERMOTT, DAVID)
Sep 18, 2003 - Aug 31, 2025
DF/HCC Kidney Cancer SPORE
Role: Co-Principal Investigator
-
R13CA088825
(KAELIN, WILLIAM G)
Jan 11, 2001 - Dec 31, 2001
CONFERENCE ON CELL CYCLE 2001
Role: Principal Investigator
-
R01CA076120
(KAELIN, WILLIAM G.)
Aug 1, 1998 - Feb 28, 2017
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer
Role: Principal Investigator
-
R01CA068490
(KAELIN, WILLIAM G.)
Aug 1, 1996 - May 31, 2017
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing
Role: Principal Investigator
-
R25CA057732
(SAWYERS, CHARLES L.)
Sep 30, 1992 - Nov 30, 2021
Molecular Biology in Clinical Oncology Workshop
Role: Co-Principal Investigator
-
F32CA008912
(KAELIN, WILLIAM G)
Dec 18, 1990
RETINOBLASTOMA SUSCEPTIBILITY GENE: FUNCTIONAL ANALYSIS
Role: Principal Investigator
-
K11CA001528
(KAELIN, WILLIAM G)
Sep 30, 1990 - Sep 29, 1995
RETINOBLASTOMA SUSCEPTIBILITY GENE--FUNCTIONAL ANALYSIS
Role: Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.